Pharmaceutical Technology, February 2022 Issue

Polymer Influence on the Rheological Properties of Co-Processed Microcrystalline Cellulose and Sodium Carboxymethylcellulose

February 03, 2022

Peer Reviewed

46

2

In this study, researchers evaluated the colloidal microcrystalline cellulose (cMCC) suspending agent—a co-processed material of microcrystalline cellulose and sodium carboxymethyl cellulose (NaCMC)—by using a representative pharmaceutical-grade commercial version of cMCC.

The Data Relationship

February 02, 2022

Quality/Regulations

46

2

As Europe moves closer to implementation of ISO IDMP standards, the bio/pharma industry is accelerating efforts to manage its data and documents more effectively.

Updated Guidance to the EU’s Digital Markets Act

February 02, 2022

Regulatory Watch

46

2

The Digital Markets Act is transforming the use of digital content by the pharmaceutical industry.

The Price Debate

February 02, 2022

From The Editor

46

2

As company revenues are gaining a boost from COVID-19, the issue of pricing is being debated once more.

Celebrate the New

February 02, 2022

From The Editor

46

2

The process of reshaping inevitably leads to fresh insights.

Environmental Monitoring Plates

February 02, 2022

Product Spotlight

46

2

Thermo Fisher Scientific's Triple Wrap Plates possess a unique Vapour-phase Hydrogen Peroxide (VHP) indicator for enhanced sterility and complete clean room and isolator confidence.

A License to Innovate

February 02, 2022

From the CEO

46

2

Busy is good for business.